Eli Lilly’s Mounjaro, Trulicity added to FDA shortage list, STATNews reports

The U.S. FDA has added Eli Lilly’s Mounjaro to its list of drugs facing shortages, highlighting the company’s struggles to meet increasing demand for the newly approved diabetes injection, STATNews’ Elaine Chen reports. Trulicity, another diabetes treatment and its biggest-selling drug, was also added to the FDA shortage list. Reference Link